Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZYY-742 gel for EGFR inhibitor–related papulopustular rash
CTR20255035Phase 2Active
- Sponsor
- Longfengtang
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of ZYY-742 in papulopustular eruption, sponsored by Longfengtang. Started Dec 2025; status: active.
02
Drugs
ZYY-742
03
Conditions
papulopustular eruption
Beyond the preview
Go deeper on CTR20255035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255035.